TY  - JOUR 
AU  - Perez de Isla, Leopoldo
AU  - Arroyo-Olivares, Raquel
AU  - Muniz-Grijalvo, Ovidio
AU  - Díaz Díaz, Jose Luis
AU  - Zambon, Daniel
AU  - Fuentes, Francisco
AU  - Sanchez Munoz-Torrero, Juan F
AU  - Mediavilla, Juan Diego
AU  - Gonzalez-Estrada, Aurora
AU  - Miramontes-Gonzalez, Jose Pablo
AU  - de Andres, Raimundo
AU  - Mauri, Marta
AU  - Mosquera, Daniel
AU  - Cepeda, Jose M
AU  - Suarez, Lorena
AU  - Barba-Romero, Miguel Angel
AU  - Argueso, Rosa
AU  - Alvarez-Banos, Pilar
AU  - Michan, Alfredo
AU  - Romero-Jimenez, Manuel J
AU  - Garcia-Cruces, Jesus
AU  - Padro, Teresa
AU  - Alonso, Rodrigo
AU  - Mata, Pedro
PY  - 2019
SN  - 1876-4789
UR  - http://hdl.handle.net/20.500.11940/15910
AB  - BACKGROUND: Maximal doses of potent statins are the basement of treatment of familial hypercholesterolemia (FH). Little is known about the use of different statin regimens in FH. OBJECTIVES: The objectives of the study were to describe the treatment...
LA  - eng
KW  - Drug Therapy
KW  - Adult
KW  - Middle Aged
KW  - Humans
KW  - Treatment Outcome
KW  - Hyperlipoproteinemia Type II
KW  - Cholesterol
KW  - Prospective Studies
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Aged
KW  - Cohort Studies
TI  - Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study
DO  - 10.1016/j.jacl.2019.10.005
T2  - J Clin Lipidol
KW  - CHUAC
VL  - 13
ER  -